How does emerging patent case law in the US and Europe affect precision medicine?

Mateo Aboy; Kathleen Liddell; Cristina Crespo; I. Glenn Cohen; Johnathon Liddicoat; Sara Gerke; Timo Minssen

doi:10.1038/s41587-019-0265-1

How does emerging patent case law in the US and Europe affect precision medicine?

Mateo Aboy
, Kathleen Liddell
, Cristina Crespo
, I. Glenn Cohen
, Johnathon Liddicoat
, Sara Gerke
, Timo Minssen

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1118-1125
Number of pages	8
Journal	Nature Biotechnology
Volume	37
Issue number	10
DOIs	https://doi.org/10.1038/s41587-019-0265-1
State	Published - Oct 1 2019

All Science Journal Classification (ASJC) codes

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Molecular Medicine
Biomedical Engineering

Access to Document

10.1038/s41587-019-0265-1

Cite this

@article{4f23f251883f487494ee6ad0e652310a,

title = "How does emerging patent case law in the US and Europe affect precision medicine?",

author = "Mateo Aboy and Kathleen Liddell and Cristina Crespo and Cohen, \{I. Glenn\} and Johnathon Liddicoat and Sara Gerke and Timo Minssen",

year = "2019",

month = oct,

day = "1",

doi = "10.1038/s41587-019-0265-1",

language = "English (US)",

volume = "37",

pages = "1118--1125",

journal = "Nature Biotechnology",

issn = "1087-0156",